These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31132650)

  • 21. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis.
    Hill HA; Qi X; Jain P; Nomie K; Wang Y; Zhou S; Wang ML
    Blood Adv; 2020 Jul; 4(13):2927-2938. PubMed ID: 32598477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
    Le Bris Y; Magrangeas F; Moreau A; Chiron D; Guérin-Charbonnel C; Theisen O; Pichon O; Canioni D; Burroni B; Maisonneuve H; Thieblemont C; Oberic L; Gyan E; Pellat-Deceunynck C; Hermine O; Delfau-Larue MH; Tessoulin B; Béné MC; Minvielle S; Le Gouill S
    Hematol Oncol; 2020 Oct; 38(4):446-455. PubMed ID: 32472610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma.
    Fang NY; Greiner TC; Weisenburger DD; Chan WC; Vose JM; Smith LM; Armitage JO; Mayer RA; Pike BL; Collins FS; Hacia JG
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5372-7. PubMed ID: 12697903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort study.
    Jeong S; Park YJ; Yun W; Lee ST; Choi JR; Suh C; Jo JC; Cha HJ; Jeong JY; Chang H; Cha YJ; Kim H; Park MJ; Song W; Cho EH; Jeong EG; Lee J; Park Y; Lee YS; Kim DJ; Lee HS
    Sci Rep; 2020 Aug; 10(1):13359. PubMed ID: 32770099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular profiling and management of mantle cell lymphoma.
    Ruan J
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):30-40. PubMed ID: 31808882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From the archives of MD Anderson Cancer Center: Untreated leukemic non-nodal mantle cell lymphoma with relapse as pleomorphic variant mantle cell lymphoma 21 years later.
    Fang H; Medeiros LJ; Tang Z; Wang W; Ok CY; Patel KP; Khoury JD; Thakral B
    Ann Diagn Pathol; 2021 Feb; 50():151649. PubMed ID: 33189964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic landscape and prognostic analysis of mantle cell lymphoma.
    Yang P; Zhang W; Wang J; Liu Y; An R; Jing H
    Cancer Gene Ther; 2018 Jun; 25(5-6):129-140. PubMed ID: 29755111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mantle cell lymphoma in the ocular adnexal region.
    Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
    Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TP53 Mutation and Complex Karyotype Portends a Dismal Prognosis in Patients With Mantle Cell Lymphoma.
    Obr A; Procházka V; Jirkuvová A; Urbánková H; Kriegova E; Schneiderová P; Vatolíková M; Papajík T
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):762-768. PubMed ID: 30146365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.
    Orchard J; Garand R; Davis Z; Babbage G; Sahota S; Matutes E; Catovsky D; Thomas PW; Avet-Loiseau H; Oscier D
    Blood; 2003 Jun; 101(12):4975-81. PubMed ID: 12609845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene mutations and actionable genetic lesions in mantle cell lymphoma.
    Ahmed M; Zhang L; Nomie K; Lam L; Wang M
    Oncotarget; 2016 Sep; 7(36):58638-58648. PubMed ID: 27449094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome.
    Rubio-Moscardo F; Climent J; Siebert R; Piris MA; Martín-Subero JI; Nieländer I; Garcia-Conde J; Dyer MJ; Terol MJ; Pinkel D; Martinez-Climent JA
    Blood; 2005 Jun; 105(11):4445-54. PubMed ID: 15718413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent Presentation of Hairy Cell Leukemia and Mantle Cell Lymphoma (Leukemic Non-Nodal Variant): An Extremely Rare Composite Lymphoma.
    Soliman DS; Ibrahim F; Fernyhough LJ; Murad F; Akiki S
    J Hematol; 2022 Feb; 11(1):21-28. PubMed ID: 35356636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.
    Nadeu F; Martin-Garcia D; Clot G; Díaz-Navarro A; Duran-Ferrer M; Navarro A; Vilarrasa-Blasi R; Kulis M; Royo R; Gutiérrez-Abril J; Valdés-Mas R; López C; Chapaprieta V; Puiggros M; Castellano G; Costa D; Aymerich M; Jares P; Espinet B; Muntañola A; Ribera-Cortada I; Siebert R; Colomer D; Torrents D; Gine E; López-Guillermo A; Küppers R; Martin-Subero JI; Puente XS; Beà S; Campo E
    Blood; 2020 Sep; 136(12):1419-1432. PubMed ID: 32584970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comprehensive Diagnosis of Mantle Cell Lymphoma].
    Yang H; Guo R; Shi Y; Wang R; Qiao C; Wu YJ; Fan L; Xu W; Li JY; Qiu HR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1720-1725. PubMed ID: 38071051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.
    Zhang J; Jima D; Moffitt AB; Liu Q; Czader M; Hsi ED; Fedoriw Y; Dunphy CH; Richards KL; Gill JI; Sun Z; Love C; Scotland P; Lock E; Levy S; Hsu DS; Dunson D; Dave SS
    Blood; 2014 May; 123(19):2988-96. PubMed ID: 24682267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations.
    Che Y; Liu Y; Yao Y; Hill HA; Li Y; Cai Q; Yan F; Jain P; Wang W; Rui L; Wang M
    Blood Cancer J; 2023 Feb; 13(1):27. PubMed ID: 36797243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage.
    Soleimani A; Navarro A; Liu D; Herman SEM; Chuang SS; Slavutsky I; Narbaitz M; Safah H; Schmieg J; Lefante J; Roschewski M; Wilson WH; Wiestner A; Saba NS
    Leuk Lymphoma; 2022 Apr; 63(4):911-917. PubMed ID: 34781807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.
    Hu Z; Sun Y; Schlette EJ; Tang G; Li S; Xu J; Yin CC; Young KH; Patel KP; Miranda RN; Goswami M; Wang M; Jorgensen JL; Medeiros LJ; Wang SA
    Mod Pathol; 2018 Feb; 31(2):327-336. PubMed ID: 28984300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.